CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
OPADE aims to improve treatment outcomes for major depressive disorders by identifying biomarkers linked to mental health. The project will analyze the interplay between genetics, microbiome, and inflammation to enhance the effectiveness of antidepressants and develop predictive tools for patient care.
280M of people worldwide suffers from major depressive disorders (MDD).
Although a well-populated therapeutic landscape of anti-depre280M of people worldwide suffers from major depressive disorders (MDD).
Although a well-populated therapeutic landscape of anti-depressants, the number of patients in remission is particularly low with not more than 6% of the patients who benefit from the current therapeutic journey. OPADE objective is to identify key biomarkers that support the decision-making pro…
EUROPEAN BIOMEDICAL RESEARCH INSTITUTE OD SALERNO
FONDAZIONE EBRIS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, Cerdanyola Del Valles (Barcelona)
Type: Research institute
Activity type: Research Organisations
SME: No
Belgium, Tienen
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
ARTIFICIAL INTELLIGENCE EXPERT SRL
Romania, Cluj Napoca
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
